In high-risk outpatients with COVID-19, remdesivir...

In high-risk outpatients with COVID-19, remdesivir reduced COVID-19-related hospitalization or all-cause death at 28 d.

Abstract

SOURCE CITATION: Gottlieb RL, Vaca CE, Paredes R, et al. Early remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med. 2022;386:305-15. 34937145.

Authors

Mourad O; Chagla Z

Journal

Annals of Internal Medicine, Vol. 175, No. 5,

Publisher

American College of Physicians

Publication Date

May 1, 2022

DOI

10.7326/j22-0026

ISSN

1056-8751

Associated Experts

Zain Chagla

Associate Professor, FHSMED

Visit profile

Labels